Molecular Partners AG
SIX:MOLN

Watchlist Manager
Molecular Partners AG Logo
Molecular Partners AG
SIX:MOLN
Watchlist
Price: 3.36 CHF -1.03%
Market Cap: 135.6m CHF

Net Margin
Molecular Partners AG

0%
Current
-1 232%
Average
-6.4%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
0%
=
Net Income
-60.2m
/
Revenue
0

Net Margin Across Competitors

No Stocks Found

Molecular Partners AG
Glance View

Market Cap
125.7m CHF
Industry
Biotechnology

Molecular Partners AG engages in the development of protein therapies for treatment of serious diseases like cancer and sight-threatening disorders. The company is headquartered in Schlieren, Zuerich and currently employs 163 full-time employees. The company went IPO on 2014-10-22. The firm has formed partnerships with leading pharmaceutical companies to advance DARPin therapeutics , and has compounds in various stages of clinical and preclinical development across multiple therapeutic areas.

MOLN Intrinsic Value
5.99 CHF
Undervaluation 44%
Intrinsic Value
Price
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
0%
=
Net Income
-60.2m
/
Revenue
0
What is the Net Margin of Molecular Partners AG?

Based on Molecular Partners AG's most recent financial statements, the company has Net Margin of 0%.

Back to Top